1.18
Talphera Inc stock is traded at $1.18, with a volume of 131.74K.
It is up +0.85% in the last 24 hours and down -4.07% over the past month.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.
See More
Previous Close:
$1.17
Open:
$1.17
24h Volume:
131.74K
Relative Volume:
0.46
Market Cap:
$61.25M
Revenue:
$1,000
Net Income/Loss:
$-14.25M
P/E Ratio:
-3.9216
EPS:
-0.3009
Net Cash Flow:
$-11.29M
1W Performance:
+1.72%
1M Performance:
-4.07%
6M Performance:
+48.17%
1Y Performance:
+30.81%
Talphera Inc Stock (TLPH) Company Profile
Compare TLPH vs TAK, TEVA, HLN, ZTS, VTRS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
TLPH
Talphera Inc
|
1.18 | 61.25M | 1,000 | -14.25M | -11.29M | -0.3009 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.86 | 60.23B | 29.91B | 1.30B | 3.49B | 0.4056 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
39.19 | 45.71B | 17.53B | 1.58B | 444.18M | 1.3457 |
|
HLN
Haleon Plc Adr
|
9.26 | 40.72B | 14.54B | 2.22B | 2.58B | 0.4871 |
|
ZTS
Zoetis Inc
|
71.05 | 29.36B | 9.51B | 2.64B | 2.14B | 6.0361 |
|
VTRS
Viatris Inc
|
17.83 | 20.48B | 14.57B | -296.50M | 1.64B | -0.259 |
Talphera Inc Stock (TLPH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-28-25 | Initiated | Rodman & Renshaw | Buy |
| Jul-20-20 | Downgrade | Credit Suisse | Neutral → Underperform |
| Nov-11-19 | Downgrade | Credit Suisse | Outperform → Neutral |
| Aug-05-19 | Resumed | Credit Suisse | Outperform |
| Jul-10-19 | Resumed | Credit Suisse | Outperform |
| Apr-24-19 | Resumed | B. Riley FBR | Buy |
| Feb-15-19 | Initiated | Credit Suisse | Outperform |
| Oct-23-18 | Initiated | B. Riley FBR | Buy |
| Oct-13-17 | Downgrade | Jefferies | Buy → Hold |
| Oct-13-17 | Reiterated | RBC Capital Mkts | Outperform |
| Jul-14-17 | Resumed | Jefferies | Buy |
| Sep-15-16 | Reiterated | ROTH Capital | Buy |
| Aug-05-16 | Downgrade | Stifel | Buy → Hold |
| Oct-30-15 | Upgrade | Jefferies | Hold → Buy |
| Oct-05-15 | Reiterated | ROTH Capital | Buy |
| Sep-02-15 | Initiated | H.C. Wainwright | Buy |
| Jul-10-15 | Resumed | ROTH Capital | Buy |
| May-06-15 | Reiterated | Mizuho | Neutral |
| May-05-15 | Reiterated | RBC Capital Mkts | Outperform |
| Mar-10-15 | Reiterated | RBC Capital Mkts | Outperform |
| Mar-09-15 | Downgrade | Mizuho | Buy → Neutral |
View All
Talphera Inc Stock (TLPH) Latest News
Talphera (TLPH) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
Why Talphera (TLPH) Just Dropped -1.26% — What to Watch 2026-09-17Runaway Gap - careplusvn.com
Talphera Inc. (NASDAQ: TLPH) Share Price, TLPH Stock News, TLPH Share Price & Updates - kalkine.com.au
Talphera to present at H.C. Wainwright Investme... - Pluang
Talphera to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - PR Newswire
Talphera Earnings Call Highlights Nafamostat Momentum - TipRanks
Talphera (TLPH) Session: Closes with Limited Movement at $1.19 in the Latest Session; Technical Setup: the Current Price Sits Inside the Supplied Technical RangeActive ETF Flow - careplusvn.com
Talphera (TLPH) Quarter in Focus: The Available Earnings Metric Delivers a Beat in the Latest Session; Market Move: Shares End With Little Net Change on the DayEarnings Per Share - vinanet.vn
Talphera (TLPH) Move: Ends Up by 0.84% at $1.20 in the Latest Session; Next Test - vinanet.vn
Talphera (TLPH) Q2 2026 Earnings Call Transcript - The Globe and Mail
Q1 2026 Talphera Inc Earnings Call Transcript - GuruFocus
Conferencia de resultados del T2 de 2026 de Talphera (TLPH): la inscripción en NEPHRO CRRT alcanza el 75 % - TradingKey
TLPH Q2 2026 Earnings: Narrower-Than-Expected Loss Delivers 11.76% EPS SurpriseDividend Growth Analysis - vinanet.vn
Talphera Inc (TLPH) Stock News Today - TradingKey
Talphera (TLPH) Gains 1.65% as Shares Approach Key Resistance at $1.29Ichimoku TK Cross - vinanet.vn
TLPH Q2 2026 Earnings: Narrower Loss Beats Estimates as Pre-Revenue Discipline HoldsEarnings Expansion Phase - vinanet.vn
HC Wainwright Has Negative View of Talphera FY2029 Earnings - MarketBeat
Talphera (TLPH) Q2 2026 Earnings Call: NEPHRO CRRT-Rekrutierung erreicht 75 % - TradingKey
Talphera (TLPH) Q2 2026 Earnings Call: NEPHRO CRRT Enrollment Reaches 75% - TradingKey
Talphera, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
H.C. Wainwright reiterates Talphera stock rating on trial progress - Investing.com
H.C. Wainwright reiterates Talphera stock rating on trial progress By Investing.com - Investing.com Canada
Talphera (TLPH) Advances NEPHRO CRRT Enrollment Amid Guideline S - GuruFocus
Talphera Inc (TLPH) (Q2 2026) Earnings Call Highlights: NEPHRO S - GuruFocus
Talphera Q2 Earnings Call Highlights - marketbeat.com
Talphera: Q2 Earnings Snapshot - AOL.com
Talphera Q2 loss narrows 40%, NEPHRO study 75% enrolled - scanx.trade
Earnings call transcript: Talphera Q2 2026 meets estimates as stock slips - Investing.com Canada
Transcript : Talphera, Inc., Q2 2026 Earnings Call, Aug 12, 2026 - marketscreener.com
Talphera (NASDAQ:TLPH) Issues Earnings Results, Meets Estimates - MarketBeat
Talphera Inc reports results for the quarter ended June 30Earnings Summary - TradingView
TALPHERA, INC. 2026: Revenue $0 Net income ($4.31M), EPS ($0.06) — 10-Q Summary - TradingView
Talphera reports Q2 2026 net loss $4.3M, cash and investments $17.1M; NEPHRO CRRT 75% enrolled - TradingView
Talphera Announces Second Quarter 2026 Financial Results and Provides Corporate Update - PR Newswire
Talphera (TLPH): Rosalind entities report 9.9% beneficial ownership cap - Stock Titan
Talphera posts $4.3 million Q2 net loss as NEPHRO CRRT enrollment reaches 75% - quiverquant.com
TLPH Q1 2026 Earnings: Narrower-Than-Expected Loss and Positive Stock MovePre-Earnings Drift - careplusvn.com
Talphera Inc expected to post a loss of 7 cents a shareEarnings Preview - TradingView
Talphera (NASDAQ:TLPH) Upgraded at Wall Street Zen - MarketBeat
Talphera Inc (TLPH) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
TLPH Q1 2026 Earnings: 43.98% EPS Surprise Reflects Cost Discipline, But Shares Stay FlatEPS Growth Report - careplusvn.com
Talphera (TLPH.US) will release its earnings report after market close on August 12. - Moomoo
Enterprise value to EBIT forward of Talphera, Inc. – DUS:R5XA - TradingView
Talphera Inc. (TLPH) Climbs 5.93% to $1.43, Approaches Key $1.50 Resistance ZoneOvervalued Signals - careplusvn.com
Talphera to Report Second Quarter 2026 Financial Results on Wednesday, August 12, 2026 - TradingView
Talphera schedules Q2 2026 results conference call and webcast - Bitget
Talphera will webcast its second-quarter financial update Aug. 12 - Stock Titan
TLPH Q1 2026 Earnings: Narrower-than-Expected Loss of $0.04 per ShareFiscal Year Earnings - careplusvn.com
TLPH|Talphera Inc|Price:1.260|Chg%:-0.090 - TradingKey
Talphera (TLPH) Holds Near Key Support After Minor PullbackFloat Adjusted Cap - dars.gov.et
Talphera, Inc. Revenue Breakdown – NASDAQ:TLPH - TradingView
Talphera Inc Stock (TLPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):